Back to results
US 2008/0177072 A1Published application
Soluble amide & ester pyrazinoylguanidine sodium channel blockers
AssigneeParion Sciences, Inc.
InventorMichael R. Johnson
Life of this patent
Estimating the term…
Abstract
The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers.
Claims2
A pyrazinoylguanidine compound represented by formula (I):
- wherein
- X is hydrogen, halogen, trifluoromethyl, lower alkyl, unsubstituted or substituted phenyl, lower alkyl-thio, phenyl-lower alkyl-thio, lower alkyl-sulfonyl, or phenyl-lower alkyl-sulfonyl;
- Y is hydrogen, hydroxyl, mercapto, lower alkoxy, lower alkyl-thio, halogen, lower alkyl, unsubstituted or substituted mononuclear aryl, or —N(R2)2;
- R1 is hydrogen or lower alkyl;
- each R2 is, independently, —R7, —(CH2)m—OR8, —(CH2)m—NR7R10, —(CH2)n(CHOR8)(CHOR8)n—CH2OR8, —(CH2CH2O)m—R8, —(CH2CH2O)m—CH2CH2NR7R10, —(CH2)n—C(═O)NR7R10, —(CH2)n-Zg-R7, —(CH2)m—NR10—CH2(CHOR8)(CHOR8)n—CH2OR8, —(CH2)n—CO2R7, or
- wherein when two —CH2OR8 groups are located 1,2- or 1,3- with respect to each other the R8 groups may be joined to form a cyclic mono- or di-substituted 1,3-dioxane or 1,3-dioxolane;
- R3 and R4 are each, independently, hydrogen, a group represented by formula (A), lower alkyl, hydroxy lower alkyl, phenyl, phenyl-lower alkyl, (halophenyl)-lower alkyl, lower-(alkylphenylalkyl), lower (alkoxyphenyl)-lower alkyl, naphthyl-lower alkyl, or pyridyl-lower alkyl, with the proviso that at least one of R3 and R4 is a group represented by formula (A):
- wherein
- each RL is, independently, —R7, —(CH2)n—OR8, —O—(CH2)n—OR8, —(CH2)n—NR7R10, —O—(CH2)m—NR7R10, —(CH2)n(CHOR8)(CHOR8)n—CH2OR8, —O—(CH2)m(CHOR8)(CHOR8)n—CH2OR8, —(CH2CH2O)m—R8, —O—(CH2CH2O)m—R8, —(CH2CH2O)m—CH2CH2NR7R10, —O—(CH2CH2O)m—CH2CH2NR7R10, —(CH2)n—C(═O)NR7R10, —O—(CH2)m—C(═O)NR7R10, —(CH2)n-(Z)g-R7, —O—(CH2)m-(Z)g-R7, —(CH2)n—NR10—CH2(CHOR8)(CHOR8)n—CH2OR8, —O—(CH2)n—NR10—CH2(CHOR8)(CHOR8)n—CH2OR8, —(CH2)n—CO2R7, —O—(CH2)m—CO2R7, —OSO3H, —O-glucuronide, —O-glucose,
- wherein when two —CH2OR8 groups are located 1,2- or 1,3- with respect to each other the R8 groups may be joined to form a cyclic mono- or di-substituted 1,3-dioxane or 1,3-dioxolane;
- each o is, independently, an integer from 0 to 10;
- each p is an integer from 0 to 10;
- with the proviso that the sum of o and p in each contiguous chain is from 1 to 10;
- each x is, independently, O, NR10, C(═O), CHOH, C(═N—R10), CHNR7R10, or represents a single bond;
- each R5 is, independently, —(CH2)n—CO2R13, Het-(CH2)m—CO2R13, —(CH2)n-Zg-CO2R13, Het-(CH2)m-Zg-CO2R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CO2R13, Het-(CH2)m—NR10—(CH2)m(CHOR8)n—CO2R13, —(CH2)n—(CHOR8)—CO2R13, Het-(CH2)m—(CHOR8)m—CO2R13, —(CH2)n—(CHOR8)mZg-CO2R13, Het-(CH2)n—(CHOR8)m-Zg-CO2R13, —(CH2)n-Zg-(CH2)m—CO2R13, —(CH2)n-Zg-(CH2)m—CO2R13, —(CH2)n-Zg(CHOR8)m-Zg-CO2R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-CO2R13, —(CH2)n—CONH—C(═NR13)—NR13R13, Het-(CH2)n—CO—NH—C(═NR13)—NR13R13, —(CH2)n-Zg-CONH—C(═NR13)—NR13R13, Het-(CH2)n-Zg-CONH—C(═NR13)—NR13R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CONH—C(═NR13)—NR13R13, Het-(CH2)n—NR10—(CH2)m(CHOR8)n—CONH—C(═NR13)—NR13R13, —(CH2)n—(CHOR8)m—CONH—C(═NR13)—NR13R13, Het-(CH2)n—(CHOR8)m—CONH—C(═NR13)—NR13R13, —(CH2)n—(CHOR8)m-Zg-CONH—C(═NR13)—NR13R13, Het-(CH2)n—(CHOR8)m-Zg-CONH—C(═NR13)—NR13R13, —(CH2)n-Zg-(CH2)mCONH—C(═NR13)—NR13R13, Het-(CH2)n-Zg-(CH2)mCONH—C(═NR13)—NR13R13, —(CH2)n-Zg-(CHOR8)m-Zg-CONH—C(═NR13)—NR13R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-CONH—C(═NR13)—NR13R13, —(CH2)n—CONR7—CONR13R13, Het-(CH2)n—CONR7—CONR13R13, —(CH2)n-Zg-CONR7—CONR13R13, —(CH2)n-Zg-CONR7—CONR13R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CONR7—CONR13R13, Het-(CH2)—NR10—(CH2)m(CHOR8)n—CONR7—CONR13R13, —(CH2)n—(CHOR8)n—CONR7—CONR13R13, Het-(CH2)n—(CHOR8)m—CONR7—CONR13R13, —(CH2)n—(CHOR8)m-Zg-CONR7—CONR13R13, Het-(CH2)n—(CHOR8)m-Zg-CNR7—CONR13R13, —(CH2)n-Zg-(CH2)mCONR7—CONR13R13, Het-(CH2)n-Zg-(CH2)mCONR7—CONR13R13, —(CH2)n-Zg(CHOR8)m-Zg-CONR7—CONR13R13, Het-(CH2)n-Zg(CHOR8)m-Zg-CONR7—CONR13R13, —(CH2)n—CONR7SO2NR13R13, Het-(CH2)m—CONR7SO2NR13R13, —(CH2)n-Zg-CONR7SO2NR13R13, Het-(CH2)m-Zg-CONR7SO2NR13R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CONR7SO2NR13R13, Het-(CH2)m—NR10—(CH2)m(CHOR8)n—CONR7SO2NR13R13, —(CH2)n—(CHOR8)m—CONR7SO2NR13R13, Het-(CH2)m—(CHOR8)m—CONR7SO2NR13R13, —(CH2)n—(CHOR8)m-Zg-CONR7SO2NR13R13Het (CH2)n—(CHOR8)m-Zg-CONR7SO2NR13R13, —(CH2)n-Zg-(CH2)mCONR7SO2NR13R13, Het-(CH2)n-Zg-(CH2)mCONR7SO2NR13R13, —(CH2)n-Zg-(CHOR9)-Zg-CONR7SO2NR13R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-CONR7SO2NR13R13, —(CH2)n—SO2NR13R13, Het-(CH2)—SO2NR13R13, —(CH2)n-Zg-SO2NR13R13, Het-(CH2)m-Zg-SO2NR13R13, —(CH2)n—NR10—(CH2)n(CHOR8)n—SO2NR13R13, Het-(CH2)m—NR10—(CH2)m(CHOR8)n—SO2NR13R13, —(CH2)n—(CHOR8)m—SO2NR13R13, Het-(CH2)m—(CHOR8)m—SO2NR13R13, —(CH2)n—(CHOR8)m-Zg-SO2NR13R13, Het-(CH2)n—(CHOR8)m-Zg-SO2NR13R13, —(CH2)n-Zg-(CH2)mSO2NR13R13, Het-(CH2)n-Zg-(CH2)mSO2NR13R13, —(CH2)n-Zg-(CHOR8)m-Zg-SO2NR13R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-SO2NR13R13, —(CH2)n—CONR13R13, Het-(CH2)n—CONR13R13, —(CH2)n-Zg-CONR13R13, Het-(CH2)m-Zg-CONR13R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CONR13R13, Het-(CH2)m—NR10—(CH2)m(CHOR8)n—CONR13R13, —(CH2)n—(CHOR8)m—CONR13R13, Het-(CH2)m—(CHOR8)m—CONR13R13, —(CH2)n—(CHOR8)-Zg-CONR13R13, Het-(CH2)n—(CHOR8)m-Zg-CONR13R13, —(CH2)n-Zg-(CH2)mCONR13R13, Het-(CH2)n-Zg-(CH2)mCONR13R13, —(CH2)n-Zg-(CHOR8)m-Zg-CONR13R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-CONR13R13, —(CH2)n—CONR7COR13, Het-(CH2)m—CONR7COR13, —(CH2)n-Zg-CONR7COR13, Het-(CH2)m-Zg-CONR7COR13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CONR7COR13, Het-(CH2)m—NR10—(CH2)m(CHOR8)n—CONR7COR13, —(CH2)n—(CHOR8)m—CONR7COR13, Het-(CH2)m—(CHOR8)m—CONR7COR13, —(CH2)n—(CHOR8)m-Zg-CONR7COR13, Het-(CH2)n—(CHOR8)m-Zg-CONR7COR13, —(CH2)n-Zg-(CH2)m—CONR7COR13, —(CH2)n-Zg-(CH2)mCONR7COR13, Het-(CH2)n-Zg-(CHOR8)m-Zg-CONR7COR13, —(CH2)n—CONR7CO2R13, —(CH2)n-Zg-CONR7CO2R13, Het-(CH2)m-Zg-CONR7CO2R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—CONR7CO2R13, Het-(CH2)m—(CH2)m(CHOR8)n—CONR7CO2R13, —(CH2)n—(CHOR8)m—CONR7CO2R13, Het-(CH2)m—(CHOR8)m—CONR7CO2R13, —(CH2)n—(CHOR8)m-Zg-(CONR7CO2R13, Het-(CH2)n—(CHOR8)m-Zg-CONR7CO2R13, —(CH2)n-Zg-(CH2)mCONR7CO2R13, Het-(CH2)n-Zg-(CH2)mCONR7CO2R13, —(CH2)n-Zg-(CHOR8)m-Zg-CONR7CO2R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-CONR7CO2R13, —(CH2)n—NH—C(═NR13)—NR13R13, Het-(CH2)n—NH—C(═NR13)—NR13R13, —(CH2)n-Zg-NH—C(═NR13)—NR13R13, Het-(CH2)m-Zg-NH—C(═NR13)—NR13R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—NH—C(═NR13)—NR13R13, Het-(CH2)m—NR10—(CH2)m—(CHOR8)n—NH—C(═NR13)—NR13R13, —(CH2)n—(CHOR8)m—NH—C(═NR13)—NR13R13, Het-(CH2)m—(CHOR8)m—NH—C(═NR13)—NR13R13, —(CH2)n—(CHOR8)m-Zg-NH—C(═NR13)—NR13R13, Het-(CH2)n—(CHOR8)m-Zg-NH—C(═NR13)—NR13R13, —(CH2)n-Zg-(CH2)mNH—C(═NR13)—NR13R13, Het-(CH2)n-Zg-(CH2)mNH—C(═NR13)—NR13R13, —(CH2)n-Zg-(CHOR8)m-Zg-NH—C(NR13)—NR13R13, Het-(CH2)n-Zg-(CHOR8)m-Zg-NH—C(═NR13)—NR13R13, —(CH2)n—C(═NR13)—NR13R13, Het-(CH2)m—C(═NH)—NR13R13, —(CH2)n-Zg-C(═NH)—NR13R13, Het-(CH2)m-Zg-C(═NH)—NR13R13, —(CH2)n—NR10—(CH2)m(CHOR8)n—C(═NR13)—NR13R13, Het-(CH2)m—NR10—(CH2)m(CHOR8)n—C(═NR13)—NR13R13, —(CH2)n(CH2)n—(CHOR8)m—C(═NR13)—NR13R13, Het-(CH2)m(CHOR8)m—C(NR13)—NR13R13, —(CH2)n—(CHOR8)m-Zg-C(═NR13)—NR13R13, Het-(CH2)n—(CHOR8)m-Zg-C(═NR13)—NR13R13, —(CH2)n-Zg-(CH2)n—C(═NHC(═NR13)—NR13R13, Het-(CH2)n-Zg-(CH2)n—C(═NR13)—NR13R13, —(CH2)n-Zg-(CHOR8)m-Zg-C(═NR13)—NR13R13, Het-(CH2)n-Zg-(CHOR8)n-Zg-C(═NR13)—NR13R13;
- wherein when two —CH2OR8 groups are located 1,2- or 1,3- with respect to each other the R8 groups may be joined to form a cyclic mono- or di-substituted 1,3-dioxane or 1,3-dioxolane;
- each R6 is, independently, —R5, —R7, —OR8, —N(R7)2, —(CH2)3—OR8, —O—(CH2)m—OR8, —(CH2)n—NR7R10, —O—(CH2)m—NR7R10, —(CH2)n(CHOR8)(CHOR8)n—CH2OR8, —O—(CH2)m(CHOR8)(CHOR8)n—CH2OR8, —(CH2CH2O)m—R8, —O—(CH2CH2O)m—R8, —(CH2CH2O)m—CH2CH2NR7R10, —O—(CH2CH2O)m—CH2CH2NR7R10, —(CH2)n—C(═O)NR7R10, —O—(CH2)m—C(═O)NR7R10, —(CH2)n-(Z)g-R7, —O—(CH2)m-(Z)g-R7, —(CH2)n—NR10—CH2(CHOR8)(CHOR8)n—CH2OR8, —O—(CH2)m—NR10—CH2(CHOR8)(CHOR8)n—CH2OR8, —(CH2)n—CO2R7, —O—(CH2)m—CO2R7, —OSO3H, —O-glucuronide, —O-glucose,
- wherein when two R6 are —OR11 and are located adjacent to each other on a phenyl ring, the alkyl moieties of the two R6 may be bonded together to form a methylenedioxy group, and
- wherein when two —CH2OR8 groups are located 1,2- or 1,3- with respect to each other the R8 groups may be joined to form a cyclic mono- or di-substituted 1,3-dioxane or 1,3-dioxolane;
- each R7 is, independently, hydrogen lower alkyl, phenyl, substituted phenyl or —CH2(CHOR)8m—R′″;
- each R8 is, independently, hydrogen, lower alkyl, —C(═O)—R11, glucuronide, 2-tetrahydropyranyl, or
- each R9 is, independently, —CO2R7, —CON(R7)2, —SO2CH3, or —C(═O)R7;
- each R′″ is, independently, —H, —SO2CH3, —CO2R7, —C(═O)NR7R9, —C(═O)R7, or —(CH2)m—(CHOH)n—CH2OH;
- each Z is, independently, CHOH, C(═O), —(CH2)n—, CHNR7R10, C═NR10, or NR10;
- each R11 is, independently, lower alkyl;
- each R12 is independently, —SO2CH3, —CO2R7, —C(═O)NR7R9, —C(═O)R7, or —CH2—(CHOH)n—CH2OH;
- each R13 is, independently, hydrogen, R7, R10, —(CH2)m—NR7R10,
- with the proviso that at least one R13 must be a group other than hydrogen, R7, or R10;
- with the additional proviso that NR13R13 can be joined on itself to form a ring comprising one of the following:
- each Het is independently, —NR7, —NR10, —S—, —SO—, —SO2—;
- —O—, —SO2NH—, —NHSO2—, —NR7CO—, or —CONR7—;
- each g is, independently, an integer from 1 to 6;
- each m is, independently, an integer from 1 to 7;
- each n is, independently, an integer from 0 to 7;
- each Q is, independently, C—R5, C—R6, or a nitrogen atom, wherein at most three Q in a ring are nitrogen atoms;
- each V is, independently, —(CH2)m—NR7R10, —(CH2)m—NR7R7, —(CH2)m—
- with the proviso that when V is attached directly to a nitrogen atom, then V can also be, independently, R7, R10, or (R11)2;
- wherein when two —CH2OR8 groups are located 1,2- or 1,3- with respect to each other the R8 groups may be joined to form a cyclic mono- or di-substituted 1,3-dioxane or 1,3-dioxolane;
- or a pharmaceutically acceptable salt thereof, and
- inclusive of all enantiomers, diastereomers, and racemic mixtures thereof.
37 more elements
2-154. (canceled)
Dependencies are inferred from the claim text.